Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Everolimus and intensive behavioral therapy in an adolescent with tuberous sclerosis complex and severe behavior.

Gipson TT, Jennett H, Wachtel L, Gregory M, Poretti A, Johnston MV.

Epilepsy Behav Case Rep. 2013 Aug 24;1:122-5. doi: 10.1016/j.ebcr.2013.06.004. eCollection 2013.

2.

Potential for treatment of severe autism in tuberous sclerosis complex.

Gipson TT, Gerner G, Wilson MA, Blue ME, Johnston MV.

World J Clin Pediatr. 2013 Aug 8;2(3):16-25. doi: 10.5409/wjcp.v2.i3.16. eCollection 2013 Aug 8. Review.

3.

Self-injury and aggression in tuberous sclerosis complex: cross syndrome comparison and associated risk markers.

Eden KE, de Vries PJ, Moss J, Richards C, Oliver C.

J Neurodev Disord. 2014;6(1):10. doi: 10.1186/1866-1955-6-10. Epub 2014 May 10.

4.

Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders.

Gipson TT, Johnston MV.

Neural Plast. 2012;2012:486402. doi: 10.1155/2012/486402. Epub 2012 Apr 30. Review.

5.

Genetic and biologic classification of infantile spasms.

Paciorkowski AR, Thio LL, Dobyns WB.

Pediatr Neurol. 2011 Dec;45(6):355-67. doi: 10.1016/j.pediatrneurol.2011.08.010. Review.

6.

An animal model to study the clinical significance of interictal spiking.

Barkmeier DT, Loeb JA.

Clin EEG Neurosci. 2009 Oct;40(4):234-8. Review.

7.

From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.

Ehninger D, de Vries PJ, Silva AJ.

J Intellect Disabil Res. 2009 Oct;53(10):838-51. doi: 10.1111/j.1365-2788.2009.01208.x. Epub 2009 Aug 19. Review.

Supplemental Content

Support Center